ACTRN12605000688684已完成1 期
A proof of concept, multi-centre evaluation of the potential beneficial effects of CB0011 when combined with CB0012 for the treatment of obstructive sleep apnea.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 21 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Subjects must have a current diagnosis of Obstructive Sleep Apnea, have an apnea-hypopnea index (AHI) of between 10-40 (using a strict definition of hypopnea), with a calculated BMI equal or less than 34 at the time of study entry.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
4 期
Food pipe narrowing caused by consuming corroding substancesCTRI/2014/05/004642Boston Scientific1
已完成
不适用
A Prospective, Multi-centre Study to Evaluate the Clinical Performance of the GYNECARE PROLIFT +M* Pelvic Floor Repair System as a Device for Pelvic Organ ProlapseProlapse1004682810029903NL-OMON31625Ethicon_Johnson & Johnson Medical Ltd20
尚未招募
不适用
A Prospective, Multi-centre Study to Evaluate the Clinical Performance of TVTO-PA as Treatment for Stress Urinary IncontinenceStress Urinary IncontinenceNL-OMON36399Johnson & Johnson100
尚未招募
2 期
AN OPEN-LABEL, MULTI-CENTRE STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF REN001 IN SUBJECTS WITH PRIMARY MITOCHONDRIAL MYOPATHY (PMM)PMMPrimary Mitochondrial Myopathy1002929910029305NL-OMON53482Reneo Pharma Ltd25
进行中（未招募）
1 期
An unblinded , multi-centre study to determine the long term safety and tolerability of the study drug REN001 in Primary Mitochondrial Myopathy (PMM) subjects.EUCTR2021-003471-34-DEReneo Pharma Ltd.200